Sai Life Sciences Limited has announced a new CMC Process R&D Center at its Hyderabad campus, set to double its Process R&D ...
Sai Life Sciences announces the groundbreaking of a state-of-the-art CMC Process R&D Center in Hyderabad, poised to double ...
Arch Biopartners (($TSE:ARCH)) announced an update on their ongoing clinical study. Arch Biopartners is conducting a Phase 2 global study titled ...
In modern regenerative science, certain research peptides—short amino-acid chains with signaling potential—draw attention for their possible roles in tissue repair, muscle regeneration, and connective ...
Scientists look to genetics to explain why GLP-1 drugs work for some people but not for others People taking popular new ...
Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback